MT-7117 clinical trials

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

This study looks at the long-term safety of a medicine called dersimelagon (MT-7117) for people with rare skin conditions called EPP or XLP. It's for those who have already been in earlier studies for this medicine.